Immediate Impact
18 from Science/Nature 60 standout
Citing Papers
Novel strategies to manage CAR-T cell toxicity
2025 Standout
Indolent CD4+ CAR T-Cell Lymphoma after Cilta-cel CAR T-Cell Therapy
2024 Standout
Works of Michael R. Bishop being referenced
Axicabtagene Ciloleucel versus Tisagenlecleucel for Relapsed or Refractory Large B Cell Lymphoma: A Systematic Review and Meta-Analysis
2024
Patterns of Use, Outcomes, and Resource Utilization among Recipients of Commercial Axicabtagene Ciloleucel and Tisagenlecleucel for Relapsed/Refractory Aggressive B Cell Lymphomas
2022
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Michael R. Bishop | 1296 | 1146 | 694 | 150 | 2.7k | |
| Christoph Faul | 1077 | 1249 | 594 | 82 | 2.4k | |
| Joseph P. Uberti | 1481 | 848 | 788 | 156 | 2.9k | |
| L Schwarzenberg | 862 | 1234 | 776 | 172 | 3.0k | |
| Francesca Bonifazi | 1719 | 818 | 655 | 141 | 3.0k | |
| Francesco Lanza | 2070 | 1007 | 889 | 158 | 3.7k | |
| H. Kabisch | 1827 | 1214 | 538 | 107 | 4.2k | |
| Subhash C. Gulati | 1241 | 896 | 267 | 86 | 2.7k | |
| Sairah Ahmed | 580 | 1326 | 498 | 210 | 2.0k | |
| Selim Corbacioglu | 1291 | 608 | 437 | 102 | 2.6k | |
| Scott R. Solomon | 2494 | 1780 | 1227 | 193 | 4.1k |
All Works
Login with ORCID to disown or claim papers
Loading papers...